Pharmabiz29m
CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B
CSL Behring's gene therapy Hemgenix four years post-infusion data continue to show sustained efficacy and safety in adults with haemophilia B: King of Prussia, Pennsylvania Monday ...
Pharmabiz59m
Piyush Goyal urges pharma industry to leverage ANRF fund for innovation at 63rd Annual Day Celebrations of IDMA in Mumbai
Shardul Nautiyal, Mumbai Monday, February 10, 2025, 14:30 Hrs [IST] ...
Pharmabiz1h
Bharat Biotech’s arm Biovet gets CDSCO nod for Biolumpivaxin, a first-ever DIVA marker vaccine to treat lumpy skin disease
Our Bureau, Bengaluru Monday, February 10, 2025, 13:45 Hrs [IST] ...
Pharmabiz1h
Pronto Consult finds therapies that have done well in January are cardiology, diabetology and pain-management
Pronto Consult finds therapies that have done well in January are cardiology, diabetology and pain-management: Our Bureau, Chennnai Monday, February 10, 2025, 13:30 Hrs [IST] Pron ...
Pharmabiz2h
AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options
AbbVie receives US FDA approval for Emblaveo to treat adults with complicated intra-abdominal infections with limited or no treatment options: North Chicago, Illinois Monday, Febr ...
Pharmabiz1h
Fennec Pharma’s partner Norgine Pharma launches Pedmarqsi in Germany
Fennec Pharma’s partner Norgine Pharma launches Pedmarqsi in Germany: Monday, February 10, 2025, 14:00 Hrs [IST] Fennec Pharmaceuticals Inc., a specialty pharmaceutical company, ...
Pharmabiz4h
Eton Pharma gets US patent covering its ET-600 product candidate’s proprietary formulation of desmopressin oral solution
Eton Pharma gets US patent covering its ET-600 product candidate’s proprietary formulation of desmopressin oral solution: Deer Park, Illinois Monday, February 10, 2025, 11:00 Hr ...
Pharmabiz5h
Eli Lilly presents positive results from VIVID-2 open-label extension study of Omvoh to treat Crohn's disease at Crohn's and Colitis Congress
Eli Lilly presents positive results from VIVID-2 open-label extension study of Omvoh to treat Crohn's disease at Crohn's and Colitis Congress: Indianapolis Monday, February 10, 20 ...
Pharmabiz7h
Sanjo College in Kerala to organise international symposium on ‘Innovations in Drug Formulations’ on Feb 21
Sanjo College in Kerala to organise international symposium on ‘Innovations in Drug Formulations’ on Feb 21: Peethaambaran Kunnathoor, Chennai Monday, February 10, 2025, 08:00 ...
Pharmabiz7h
Indian pharma to expand to Africa, South America & South Asia as China+1 strategy gains ground
Nandita Vijayasimha, Bengaluru Monday, February 10, 2025, 08:00 Hrs [IST] ...
Pharmabiz6h
CSIR-NIIST develops technology for converting biomedical waste into soil additives
CSIR-NIIST develops technology for converting biomedical waste into soil additives: Our Bureau, Mumbai Monday, February 10, 2025, 09:00 Hrs [IST] Union minister for science and te ...
Pharmabiz7h
Panel asks govt to ensure consistent supply of drugs, scaling up testing facilities against TB
Panel asks govt to ensure consistent supply of drugs, scaling up testing facilities against TB: Gireesh Babu, New Delhi Monday, February 10, 2025, 08:00 Hrs [IST] A Parliamentary ...